Article

Dysfunctional tear syndrome deemed more accurate term

Dry eye syndrome, now called dysfunctional tear syndrome, is a complex scenario of signs and symptoms.

Baltimore-Dry eye syndrome, now called dysfunctional tear syndrome (DTS), is a complex scenario of signs and symptoms. The complexity of the clinical picture dictates the treatment strategy. Lid margin disease probably is more frequent than previously thought in dry eye syndrome.

"The new name for dry eye, DTS, was accepted because the original name was misleading to patients, who often have watery eyes," said Dr. Behrens, executive medical director, King Khaled Eye Specialist Hospital (KKESH), Riyadh, Saudi Arabia, and holder of the endowed KKESH/Wilmer Professorship in International Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore.

"Therapy for DTS should be based on signs and symptoms because the standard tests, such as Schirmer's test and tear break-up time, do not reflect the disease severity," he added.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.